Possible treatment of circadian sleep disorders using daily ketotifen administration
Classic H 1 histamine receptor (H 1 R) antagonists are currently used as over-the-counter sleep aids. However, their overdose administrations rather produce wakefulness. Our previous rat model studies suggest that ketotifen, an early-phase, second-generation H 1 R antagonist may be a more desirable...
Saved in:
Published in | Sleep and biological rhythms Vol. 14; no. 1; pp. 117 - 120 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
Springer Japan
01.01.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Classic H
1
histamine receptor (H
1
R) antagonists are currently used as over-the-counter sleep aids. However, their overdose administrations rather produce wakefulness. Our previous rat model studies suggest that ketotifen, an early-phase, second-generation H
1
R antagonist may be a more desirable sleep aid. Here, we further examined daily injections of ketotifen (3 mg/kg, intraperitoneally, for 5 days) 3 h before light onset time in rats and analyzed the effect of ketotifen on the successive free-running locomotor activity rhythms under constant dim red light. We found significant phase-advancement by the daily ketotifen injections, suggesting possible treatment of circadian sleep disorders using daily ketotifen administration. |
---|---|
ISSN: | 1446-9235 1479-8425 |
DOI: | 10.1007/s41105-015-0021-y |